International Journal of Clinical Research

Objective To explore the clinical effect of minimally invasive surgery in the treatment of patients with moderate-volume hypertensive intracerebral hemorrhage (HICH), and to provide a reference for clinical treatment plans. Methods From October 2024 to October 2025, 100 patients with moderate-volume hypertensive intracerebral hemorrhage admitted to our hospital were selected and divided into the control group and the experimental group, with 50 cases in each group. The control group received traditional conservative treatment, while the experimental group received minimally invasive surgery. The clinical efficacy, neurological deficit score (NIHSS), hematoma clearance rate, hospital stay, and complication rate of the two groups were compared and statistically analyzed. Results The total effective rate of the experimental group was 94.00%, significantly higher than that of the control group (78.00%) (P < 0.05); 7 days and 14 days after treatment, the NIHSS score of the experimental group was significantly lower than that of the control group (P < 0.05); the hematoma clearance rate of the experimental group was (89.63 ± 5.27)%, significantly higher than that of the control group (62.35 ± 7.14)%, and the hospital stay of the experimental group was (14.23 ± 3.15) days, significantly shorter than that of the control group (21.56 ± 4.28) days (P < 0.05); the complication rate of the experimental group was 6.00%, significantly lower than that of the control group (20.00%) (P < 0.05). Conclusion Minimally invasive surgery for patients with moderate-volume hypertensive intracerebral hemorrhage can improve hematoma clearance rate, improve neurological function, shorten hospital stay, and reduce complication rate, with significant clinical efficacy, and is worthy of promotion.

Hypertensive intracerebral hemorrhage; Small amount of hemorrhage; Minimally invasive surgery; Neurological function; Clinical efficacy